English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5428]
News [12614]
Articles [173]
Editorials [5]
Conferences [246]
elearning [17]
Updates in targeted therapy for melanoma
Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany
Updates in targeted therapy for melanoma ( Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany )
3 Jun 2018
Health related quality of life findings from COMBI-AD
Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany
Health related quality of life findings from COMBI-AD ( Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany )
3 Jun 2018
Developing a survivin vaccine for glioblastoma
Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Developing a survivin vaccine for glioblastoma ( Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
3 Jun 2018
Early results from a 3rd gen EGFR-TKI in advanced NSCLC
Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea
Early results from a 3rd gen EGFR-TKI in advanced NSCLC ( Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea )
3 Jun 2018
OPTIMISMM trial for refractory multiple myeloma
Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA
OPTIMISMM trial for refractory multiple myeloma ( Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA )
3 Jun 2018
Treatment updates in Merkel cell carcinoma
Dr Paul Nghiem - University of Washington, Seattle, USA
Treatment updates in Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )
3 Jun 2018
Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast...
Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany
Results from the LILAC study of ABP 980 with trastuzumab for HER2  early breast cancer ( Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany )
3 Jun 2018
New treatment markers for myeloma
Dr Jesus San Miguel - Universidad de Navarra, Pamplona, Spain
New treatment markers for myeloma ( Dr Jesus San Miguel - Universidad de Navarra, Pamplona, Spain )
3 Jun 2018
Most breast cancer patients could avoid chemo with use of genetic testing
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Most breast cancer patients could avoid chemo with use of genetic testing ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
3 Jun 2018
Pembrolizumab works better than chemotherapy alone as initial treatment for...
Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA
Pembrolizumab works better than chemotherapy alone as initial treatment for NSCLC ( Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA )
3 Jun 2018
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma ( Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy )
3 Jun 2018
Sunitinib with or without surgery for metastatic renal cell carcinoma
Prof Arnaud Mejean - Paris Descartes University, Paris, France
Sunitinib with or without surgery for metastatic renal cell carcinoma ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )
3 Jun 2018
<1...229230231232233...453>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top